ReviewCancers2024
An Updated Review of Management of Resectable Stage III NSCLC in the Era of Neoadjuvant Immunotherapy.
Saurav Verma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ReviewCancers2024
Saurav Verma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.